Clinical trial
A Randomized, Double-blind, Cross-over Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy Subjects
NCT02191462 is registered in ClinicalTrials.gov with KGK Science Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Cross-over Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy Subjects
- Lead sponsor
- KGK Science Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- August 31, 2014
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pharmacokinetics